Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Factors influencing warfarin dose requirements in African-Americans.

Pharmacogenomics - 1 Nov 2007

Momary Kathryn M, Shapiro Nancy L, Viana Marlos Ag, Nutescu Edith A, Helgason Cathy M, Cavallari Larisa H

Abstract excerpt

INTRODUCTION: African-Americans are under-represented in studies assessing contributors to warfarin response. Our primary objective was to determine whether the genes for cytochrome P450 (CYP) 2C9, nicotinamide adenine dinucleotide phosphate, reduced, quinone oxidoreductase (NQO1) and vitamin K epoxide reductase complex subunit 1 (VKORC1) are associated with warfarin dose requirements in African-Americans....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anticoagulants
Share to Cytochrome P-450 CYP2C9
Share to Feeding Behavior

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to NAD(P)H Dehydrogenase (Quinone)

Share to Thromboembolism

Share to Vitamin K

Share to Vitamin K Epoxide Reductases

Share to Warfarin

Source

Identifiers

PMID: 18034618
DOI: 10.2217/14622416.8.11.1535

Genes

VKORC1
NQO1

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Factors influencing warfarin dose requirements in African-Americans.PMID 18034618Read ↗

Genetic and clinical predictors of warfarin dose requirements in African Americans.Semantic proximity Read ↗

Influence of coagulation factor, vitamin K epoxide reductase complex subunit 1, and cytochrome P450 2C9 gene polymorphisms on warfarin dose requirements.Semantic proximity Read ↗

Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study.Semantic proximity Read ↗

Genetic Factors Influencing Warfarin Dose in Black-African Patients: A Systematic Review and Meta-Analysis.Semantic proximity Read ↗

The future of warfarin pharmacogenetics in under-represented minority groups.Semantic proximity Read ↗

Predictors of warfarin dose requirements in South African patients attending an anticoagulation clinic.Semantic proximity Read ↗

CYP2C9*8 is Prevalent Among African–Americans: Implications for Pharmacogenetic DosingSemantic proximity Read ↗

Genetic and nongenetic factors associated with warfarin dose requirements in Egyptian patients.Semantic proximity Read ↗

Implications of Polymorphisms in the BCKDK and GATA-4 Gene Regions on Stable Warfarin Dose in African Americans.Semantic proximity Read ↗

Effect of NQO1 and CYP4F2 genotypes on warfarin dose requirements in Hispanic-Americans and African-Americans.Semantic proximity Read ↗

Warfarin pharmacogenomics.Semantic proximity Read ↗

The missing association: sequencing-based discovery of novel SNPs in VKORC1 and CYP2C9 that affect warfarin dose in African Americans.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.